Search
for

    Sort by

    Research 421–450 of 1000+

    1. The effect of weight loss and treatment with metformin on serum vaspin levels in women with polycystic ovary syndrome Endocrine Journal · 2011 · 38 citations
    2. Surrogate end-points or primary outcomes in clinical trials in women with polycystic ovary syndrome? Human Reproduction · 2004 · 38 citations
    3. Effects of PNU157706, a Dual 5α-Reductase Inhibitor, on Rat Epididymal Sperm Maturation and Fertility1 Biology of Reproduction · 2004 · 35 citations
    4. Polycystic Ovarian Syndrome: Long-Term Health Consequences Seminars in Reproductive Medicine · 2017 · 34 citations
    5. Polycystic ovary syndrome is associated with anogenital distance, a marker of prenatal androgen exposure Human Reproduction · 2017 · 32 citations
    6. Female pattern hair loss, sebum excretion and the end-organ response to androgens British Journal of Dermatology · 2005 · 31 citations
    7. Carriers of 21-Hydroxylase Deficiency Are Not at Increased Risk for Hyperandrogenism* The Journal of Clinical Endocrinology and Metabolism · 1997 · 31 citations
    8. Androgen Receptor Accelerates Premature Senescence of Human Dermal Papilla Cells in Association with DNA Damage PLOS ONE · 2013 · 30 citations
    9. Effect of finasteride, a 5 alpha-reductase inhibitor, on serum gonadotropins in normal men. The Journal of Clinical Endocrinology and Metabolism · 1992 · 30 citations
    10. Serum lipocalin-2 as an insulin resistance marker in patients with polycystic ovary syndrome Journal of Endocrinological Investigation · 2010 · 29 citations
    11. Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with polycystic ovary syndrome Gynecological Endocrinology · 2009 · 29 citations
    12. Elevated serum androstenedione is associated with a more severe phenotype in women with polycystic ovary syndrome (PCOS) Hormones · 2014 · 28 citations
    13. Phenotypic comparison of Caucasian and Asian women with polycystic ovary syndrome: a cross-sectional study Fertility and Sterility · 2013 · 28 citations
    14. Polycystic ovary syndrome is associated with atherogenic changes in lipoprotein particle number and size independent of body weight Clinical Endocrinology · 2011 · 28 citations
    15. Is Xanthine oxidase activity in polycystic ovary syndrome associated with inflammatory and cardiovascular risk factors? Journal of Reproductive Immunology · 2016 · 26 citations
    16. Insulin resistance and its relationship with high molecular weight adiponectin in adolescents with polycystic ovary syndrome and a maternal history of polycystic ovary syndrome Fertility and Sterility · 2014 · 26 citations
    17. Combined Oral Contraception and Bicalutamide in Polycystic Ovary Syndrome and Severe Hirsutism: A Double-Blind Randomized Controlled Trial The Journal of Clinical Endocrinology & Metabolism · 2017 · 25 citations
    18. A missing piece: the spiny mouse and the puzzle of menstruating species Journal of Molecular Endocrinology · 2018 · 24 citations
    19. Analysis of quantitative changes in hair growth during treatment with chemotherapy or tamoxifen in patients with breast cancer: a cohort study British Journal of Dermatology · 2013 · 24 citations
    20. The Modified Ferriman-Gallwey Score and Hirsutism among Filipino Women Endocrinology and metabolism · 2019 · 22 citations
    21. Graham Little-Piccardi-Lassueur syndrome associated with androgen insensitivity syndrome (testicular feminization) Journal of The European Academy of Dermatology and Venereology · 2004 · 22 citations
    22. Testosterone implants in women: Pharmacological dosing for a physiologic effect Maturitas · 2012 · 21 citations
    23. Hormonal Parameters in Androgenetic Hair Loss in the Male Dermatology · 2009 · 21 citations
    24. Ovarian morphology and prevalence of polycystic ovary syndrome in reproductive aged women with or without mild acne International Journal of Dermatology · 2010 · 20 citations
    25. Decreased lipin 1β expression in visceral adipose tissue is associated with insulin resistance in polycystic ovary syndrome European journal of endocrinology · 2008 · 20 citations
    26. A variant of the glucocorticoid receptor gene is not associated with adrenal androgen excess in women with polycystic ovary syndrome Fertility and Sterility · 2000 · 20 citations
    27. Infertility Treatment in Polycystic Ovary Syndrome: Lifestyle Interventions, Medications and Surgery Frontiers of Hormone Research · 2012 · 19 citations
    28. Characterization of metabolic changes in the phenotypes of women with polycystic ovary syndrome in a large Mediterranean population from Sicily Clinical Endocrinology · 2019 · 18 citations
    29. Serum vascular endothelial growth factor B is elevated in women with polycystic ovary syndrome and can be decreased with metformin treatment Clinical Endocrinology · 2015 · 18 citations
    30. Expression of 11β-hydroxysteroid dehydrogenase type 1 in visceral and subcutaneous adipose tissues of patients with polycystic ovary syndrome is associated with adiposity The Journal of Steroid Biochemistry and Molecular Biology · 2010 · 18 citations